Average Co-Inventor Count = 4.10
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (22 from 2,070 patents)
2. Ortho-mcneil Pharmaceutical Corp. (22 from 360 patents)
3. Biohaven Therapeutics Ltd. (11 from 27 patents)
4. Biohaven Pharmaceutical Holding Company Limited (8 from 8 patents)
5. Mcneil Ab (7 from 187 patents)
6. The Wistar Institute of Anatomy & Biology (7 from 156 patents)
7. Other (4 from 831,952 patents)
8. Rutgers, the State University of New Jersey (4 from 1,430 patents)
9. The Scripps Research Institute (4 from 1,182 patents)
10. Ortho Pharmaceutical Corporation (3 from 377 patents)
11. Oligomerix, Inc. (3 from 10 patents)
12. University of Pennsylvania (2 from 2,544 patents)
13. Musc Foundation for Research Development (2 from 172 patents)
14. Yale University (1 from 1,312 patents)
15. Johnson & Johnson Consumer Companies, Inc. (1 from 271 patents)
100 patents:
1. 12343347 - Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis
2. 12331043 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use
3. 12295942 - Riluzole prodrugs and their use
4. 12258314 - EBNA1 inhibitors and their method of use
5. 12213965 - Riluzole prodrugs and their use
6. 12172974 - Prodrugs of riluzole and their method of use
7. 12029731 - Acyl benzo[d]thiazol-2-amine and their methods of use
8. 12030868 - Prodrugs of CGRP antagonists
9. 12005046 - Riluzole prodrugs and their use
10. 12005047 - Riluzole prodrugs and their use
11. 11912659 - EBNA1 inhibitors and methods using same
12. 11911369 - Prodrugs of riluzole and their method of use
13. 11731952 - Indene derivatives and uses thereof
14. 11472776 - Quinazolinones that inhibit the formation of tau oligomers and their method of use
15. 11440893 - Prodrugs of riluzole and their method of use